1931 related articles for article (PubMed ID: 26482310)
1. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Keniya MV; Ruma YN; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
9. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
10. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
Wu Y; Gao N; Li C; Gao J; Ying C
FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124
[TBL] [Abstract][Full Text] [Related]
11. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
[TBL] [Abstract][Full Text] [Related]
12.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
13. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
15. Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Król J; Nawrot U; Bartoszewicz M
J Mycol Med; 2018 Jun; 28(2):327-331. PubMed ID: 29605543
[TBL] [Abstract][Full Text] [Related]
16. A Transcriptomics Approach To Unveiling the Mechanisms of
Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
[No Abstract] [Full Text] [Related]
17. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
18. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
19. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
20. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Morio F; Loge C; Besse B; Hennequin C; Le Pape P
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):373-84. PubMed ID: 20226328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]